These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754 [TBL] [Abstract][Full Text] [Related]
7. Rate of Pathogenic Germline Variants in Patients With Lung Cancer. Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258 [TBL] [Abstract][Full Text] [Related]
8. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. LaDuca H; Polley EC; Yussuf A; Hoang L; Gutierrez S; Hart SN; Yadav S; Hu C; Na J; Goldgar DE; Fulk K; Smith LP; Horton C; Profato J; Pesaran T; Gau CL; Pronold M; Davis BT; Chao EC; Couch FJ; Dolinsky JS Genet Med; 2020 Feb; 22(2):407-415. PubMed ID: 31406321 [TBL] [Abstract][Full Text] [Related]
9. PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? Mester JL; Moore RA; Eng C Oncologist; 2013; 18(10):1083-90. PubMed ID: 24037976 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study. Abdel-Razeq H; Al-Azzam K; Elemian S; Abu-Fares H; Abu Sheikha A; Bani Hani H; Bater R; Sharaf B; Heald B; Esplin ED; Nielsen SM; Alkyam M; Abujamous L; Al-Attary A Mol Genet Genomic Med; 2023 Apr; 11(4):e2125. PubMed ID: 36537080 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial. Shore N; Gazi M; Pieczonka C; Heron S; Modh R; Cahn D; Belkoff LH; Berger A; Mazzarella B; Veys J; Idom C; Morris D; Jayram G; Engelman A; Bukkapatnam R; Dato P; Bevan-Thomas R; Cornell R; Wise DR; Hardwick MK; Hernandez RD; Rojahn S; Layman P; Hatchell KE; Heald B; Nussbaum RL; Nielsen SM; Esplin ED Eur Urol Oncol; 2023 Oct; 6(5):477-483. PubMed ID: 37574391 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. Hutchcraft ML; Zhang S; Lin N; Pickarski JC; Belcher EA; Wei S; Bocklage T; Miller RW; Villano JL; Cavnar MJ; Kim J; Arnold SM; Ueland FR; Kolesar JM JCO Precis Oncol; 2024 Jan; 8():e2300266. PubMed ID: 38295319 [TBL] [Abstract][Full Text] [Related]
13. Utility of germline multi-gene panel testing in patients with endometrial cancer. Karpel HC; Chern JY; Smith J M; Smith A J; Pothuri B Gynecol Oncol; 2022 Jun; 165(3):546-551. PubMed ID: 35483985 [TBL] [Abstract][Full Text] [Related]
14. Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer. Berchuck JE; Boiarsky D; Silver R; Sunkara R; McClure HM; Tsai HK; Siegmund S; Tewari AK; Nowak JA; Lindeman NI; Rana HQ; Choudhury AD; Pomerantz MM; Freedman ML; Van Allen EM; Taplin ME JCO Precis Oncol; 2022 Aug; 6():e2200329. PubMed ID: 36103646 [TBL] [Abstract][Full Text] [Related]
15. Genetic testing by cancer site: uterus. Daniels MS Cancer J; 2012; 18(4):338-42. PubMed ID: 22846735 [TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study. Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015 [TBL] [Abstract][Full Text] [Related]
17. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study. Uson PLS; Riegert-Johnson D; Boardman L; Kisiel J; Mountjoy L; Patel N; Lizaola-Mayo B; Borad MJ; Ahn D; Sonbol MB; Jones J; Leighton JA; Gurudu S; Singh H; Klint M; Kunze KL; Golafshar MA; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab TS; Jewel Samadder N Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e508-e528. PubMed ID: 33857637 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma. Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863 [TBL] [Abstract][Full Text] [Related]
19. Lynch Syndrome in Thai Endometrial Cancer Patients. Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176 [TBL] [Abstract][Full Text] [Related]
20. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]